Expertise in
3
conditions

Vsevolod B. Matveev

Federal State Budgetary Institution оF The Ministry Of Health Of The Russian Federation
Moscow, MOW, RU 
Expertise in
3
conditions
Federal State Budgetary Institution оF The Ministry Of Health Of The Russian Federation
Moscow, MOW, RU 

Overview

Vsevolod Matveev practices practicing medicine in Moscow, Russian Federation.

Mr. Matveev is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Penile Cancer, Prostate Cancer, Prostatectomy, and Thrombectomy.

He is actively involved in clinical research, co-authoring 322 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Federal State Budgetary Institution оf the Ministry of Health of the Russian Federation
Moscow, MOW, Russian Federation
Other Locations
Dubna, KLU, Russian Federation
Russian Federation
Gatchina, SMO, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Fuzuloparib+Abiraterone Acetate+Prednisone
Study Phase: Phase 3
Multicenter, Randomized, Single-blind Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer
Multicenter, Randomized, Single-blind Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer
Enrollment Status: Completed
Publish Date: September 20, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

322 Total Publications

Assessment of EGFR and HER2 expression in penile cancer as potential therapeutic targets.
Assessment of EGFR and HER2 expression in penile cancer as potential therapeutic targets.
Journal: Virchows Archiv : an international journal of pathology
Published: March 22, 2026

Frequently Asked Questions about Vsevolod B. Matveev

Is Vsevolod B. Matveev a top-rated expert for Renal Cell Carcinoma (RCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Vsevolod B. Matveev is classified as an Distinguished expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vsevolod B. Matveev participate in research or clinical trials?

Yes. Vsevolod B. Matveev has published 322 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Vsevolod B. Matveev's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Matveev's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile